Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces

CMAJ. Canadian Medical Association Journal

Volumn 165, Issue 3, 2001, Pages 277-283

  Olivotto, I A ^a   Bancej, C ^a   Goel, V ^a   Snider, J ^a   McAuley, R G ^a   Irvine, B ^a   Kan, L ^a   Mirsky, D ^a   Sabine, M J ^a   McGilly, R ^a   Caines, J S ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANADA; CANCER DIAGNOSIS; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; TUMOR BIOPSY;

EID: 0034827737     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Breast cancer screening programmes in 22 countries: Current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening
2. Report of the international workshop on screening for breast cancer
3. Breast cancer screening with mammography: Overview of Swedish randomised trials
4. Efficacy of screening mammography. A meta-analysis
5. Breast cancer screening in 21 countries: Delivery of services, notification of results and outcomes ascertainment
6. Clinical practice guidelines for the care and treatment of breast cancer: 2. Investigation of lesions detected by mammography
7. Clinical practice guidelines for the care and treatment treatment of breast cancer: 1. The palpable breast lump: Information and recommendations to assist decision-making when a breast lump is detected
8. Nova Scotia Breast Screening Program experience: Use of needle core biopsy in the diagnosis of screening-detected abnormalities
9. Pensive women, painful vigils: Consequences of delay in assessment of mammographic abnormalities
10. Psychiatric morbidity associated with screening for breast cancer
11. Assessment of the psychological impact of a breast screening programme
12. Breast screening: Adverse psychological consequences one month after placing women on early recall because of a diagnostic uncertainty. A multicentre study
13. Do women who undergo further investigation for breast screening suffer adverse psychological consequences? A multi-centre follow-up study comparing different breast screening result groups five months after their last breast screening appointment
14. The experience of waiting for a diagnosis after an abnormal mammogram
15. Performance of screening mammography in organized programs in Canada in 1996
16. Trends in mammography utilization, 1981 to 1994
17. Ten years of breast screening in the Screening Mammography Program of British Columbia, 1988-97
18. Quality assurance and cancer detection rates in a provincial screening mammography program. Work in progress
19. Results from the Ontario breast screening program, 1990-1995
20. Organized breast cancer screening programs in Canada
21. Psychological consequences of screening mammography
22. The psychological consequences of mammography
23. Psychological and behavioral implications of abnormal mammograms
24. Recalling women for further investigation of breast screening: Women's experiences at the clinic and afterwards
25. Waiting times for surgical procedures
26. Influence of delay on survival in patients with breast cancer: A systematic review
27. Image-guided breast biopsy: How, when, and by whom?
28. Changing to core biopsy in an NHS breast screening unit
29. Stereotactic core biopsy reduces the reexcision rate and the cost of mammographically detected cancer
30. The British Columbia Mammography Screening Program: Evaluation of the first 15 months
31. Delay from symptom to diagnosis and treatment of breast cancer in Washington State and British Columbia
32. Timeliness of follow-up after abnormal screening mammography
33. Maximum waiting time: A threat to clinical freedom?. Implementation of a policy to reduce waiting times